SKI Market

A+| A| A-|

Indian Indices

Sensex

76,899.77 -663.13
( -0.85%)

Global Indices

Nasdaq

47,935.11 1,329.65
(2.85%)

Dow Jones

6,804.45 166.60
(2.51%)

Hang Seng

55,958.99 -349.43
(-0.62%)

Nikkei 225

10,596.41 247.62
(2.39%)

Forex

USD-INR

92.90 -0.03
(-0.03%)

EUR-INR

107.45 0.22
(0.21%)

GBP-INR

123.16 0.23
(0.18%)

JPY-INR

0.58 0.00
(-0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5542386

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

21.44

98210.21

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.32

Back

Redington consolidated net profit rises 32.42% in the September 2025 quarter

Nov 06,2025

Net profit of Redington rose 32.42% to Rs 387.83 crore in the quarter ended September 2025 as against Rs 292.87 crore during the previous quarter ended September 2024. Sales rose 16.79% to Rs 29075.61 crore in the quarter ended September 2025 as against Rs 24895.56 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	29075.61	24895.56	17
OPM %	2.03	1.84	-
PBDT	515.22	430.82	20
PBT	459.76	381.33	21
NP	387.83	292.87	32

76,899.77 -663.13 ( -0.85%)

47,935.11 1,329.65 (2.85%)

6,804.45 166.60 (2.51%)

55,958.99 -349.43 (-0.62%)

10,596.41 247.62 (2.39%)

92.90 -0.03 (-0.03%)

107.45 0.22 (0.21%)

123.16 0.23 (0.18%)

0.58 0.00 (-0.10%)